Get Help Now
Free Consultation 866.897.8495
Close

Home
Select Category
Byetta,®Januvia,® Onglyza,® Tradjenta,® and Victoza® Cancer Risks

Prescribed to improve blood sugar levels in Type 2 diabetes patients, a variety of popular Type 2 diabetes drugs have been linked to serious health problems in some patients, including pancreatic cancer.

You may be entitled to compensation if you or a loved one developed pancreatic cancer after taking:

  • Onglyza®
  • Byetta®
  • Januvia®
  • Janumet®
  • Tradjenta®
  • Victoza®

Our drug injury lawyers aren’t afraid to take on big pharmaceutical companies, and we’re here to help protect your rights. Don’t wait—there are strict deadlines to take legal action. Call or contact us online today to get started now. 

We Want to Help

Pancreatic cancer is an extremely serious condition, and the medical bills, lost wages, and pain and suffering that result can leave you wondering how you’ll support yourself and your family. Our law firm wants to help if you or a loved one suffered after taking a Type 2 diabetes drug. Call us or fill out a free online consultation form, and a member of our legal team will contact you to discuss your case.

Byetta® and Onglyza® are registered trademarks of AstraZeneca. Januvia® and Janumet® are registered trademarks of Merck & Co., Inc. Tradjenta® is a registered trademark of Boehringer Ingelheim GmbH & Co. Victoza® is a registered trademark of Novo Nordisk A/S.

This law firm is not associated with, sponsored by, or affiliated with AstraZeneca; Merck & Co., Inc.; Boeringer Ingelheim GmbH & Co.; or Novo Nordisk A/S.